| Indicator | Cohort (n=82) | Abnormal group (n=23) | Normal group (n=59) |
|---|
| Gender/(n%) | | | | | Male | 45 (54.9) | 17 (73.9) | 28 (47.5) | | Female | 37 (45.1) | 6 (26.1) | 31 (52.5) | | Age of operation/month | 7.00 (5.00, 11.50) | 7.50 (5.25, 13.00) | 6.00 (5.00, 10.50) | | Height/cm | 65.00 (62.00, 72.00) | 65.00 (63.00, 79.00) | 65.00 (62.00, 71.50) | | Weight/kg | 7.15 (6.00, 8.75) | 7.30 (6.40, 10.67) | 7.10 (5.85, 8.30) | | BMI/(kg·m-2) | 15.95 (14.48, 17.19) | 16.35 (14.72, 17.74) | 15.59 (14.29, 17.04) | | GRWR | 3.70 (3.02, 4.39) | 3.81 (2.56, 4.21) | 3.71 (3.15, 4.47) | | Blood type of recipient/(n%) | | | | | O | 21 (25.6) | 4 (17.4) | 17 (28.8) | | A | 24 (29.3) | 8 (34.8) | 16 (27.1) | | B | 29 (35.4) | 6 (26.1) | 23 (39.0) | | AB | 8 (9.8) | 5 (21.7) | 3 (5.1) | | Blood type of donor/(n%) | | | | | O | 24 (29.3) | 4 (17.4) | 20 (33.9) | | A | 22 (26.8) | 9 (39.1) | 13 (22.0) | | B | 30 (36.6) | 8 (34.8) | 22 (37.3) | | AB | 6 (7.3) | 2 (8.7) | 4 (6.8) | | Blood type compatibility/(n%) | | | | | Yes | 13 (15.9) | 2 (8.7) | 11 (18.6) | | No | 69 (84.1) | 21 (91.3) | 48 (81.4) | | CYP genotyping of recipient/(n%) | | | | | 1×1 | 9 (11.0) | 1 (4.4) | 8 (13.6) | | 1×3 | 37 (45.1) | 11 (47.8) | 26 (44.0) | | 3×3 | 36 (43.9) | 11 (47.8) | 25 (42.4) | | CYP genotyping of donors/(n%) | | | | | 1×1 | 8 (9.8) | 3 (13.0) | 5 (8.5) | | 1×3 | 28 (34.1) | 6 (26.1) | 22 (37.3) | | 3×3 | 46 (56.1) | 14 (60.9) | 32 (54.2) | | Whether mycophenolate mofetil was administered/(n%) | | | | | Yes | 18 (22.0) | 4 (17.4) | 14 (23.7) | | No | 64 (78.0) | 19 (82.6) | 45 (76.3) | | Occurrence of CMV infection/(n%) | | | | | Yes | 13 (15.9) | 9 (39.1) | 4 (6.8) | | No | 69 (84.1) | 14 (60.9) | 55 (93.2) |
|